Colleen DeSimone has more than 25 years of strategic financial and operational experience in the biotechnology and pharmaceutical industries. Most recently, she provided financial consulting services for Casma since its inception and for numerous early-stage biotechnology companies. Previously, Colleen served as vice president of finance and controller at Syros Pharmaceuticals. Colleen joined Syros from Takeda Pharmaceuticals, where she served as senior director, finance, and controller, responsible for all aspects of financial reporting, accounting, and internal controls of Takeda’s oncology business unit. She held several positions of increasing financial and operational responsibility at Millennium Pharmaceuticals before its acquisition by Takeda in 2008. Colleen began her career at Deloitte LLP in Boston, where she worked with a variety of public and private audit clients. Colleen serves on the board of the Joe Andruzzi Foundation, a non-profit organization that provides direct financial assistance to New England cancer patients and their families. She received a B.A. in economics – accounting from the College of the Holy Cross.